✦ LIBER ✦

628 Targeting Bcr/Abl and Src family kinases reverses Imatinib mesylate resistance in CML

✍ Scribed by J.Y. Wu; M. Talpaz; J. Stapley; S. Lee; N. Donato

Book ID: 118621810
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 147 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80636-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of dual-specific Bcr-Abl and Sr

Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate

✍ Tipping, A J; Baluch, S; Barnes, D J; Veach, D R; Clarkson, B M; Bornmann, W G; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

STI-571 (Imatinib Mesylate) Enhances the

STI-571 (Imatinib Mesylate) Enhances the Apoptotic Efficacy of Pyrrolo-1,5-Benzoxazepine-6, a Novel Microtubule-Targeting Agent, in Both STI-571-Sensitive and -Resistant Bcr-Abl-Positive Human Chronic Myeloid Leukemia Cells

✍ Greene, L. M.; Kelly, L.; Onnis, V.; Campiani, G.; Lawler, M.; Williams, D. C.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 463 KB